End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 CNY | +2.06% |
|
+5.04% | -7.09% |
01-29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
10-25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
2 | ||||||||
16 | ||||||||
13 | ||||||||
8 | ||||||||
12 | ||||||||
16 | ||||||||
3 | ||||||||
- | 1 | |||||||
5 | ||||||||
- | - | |||||||
5 | ||||||||
3 | ||||||||
- | 1 | |||||||
- | - | 1 | ||||||
- | 2 | |||||||
13 | ||||||||
5 | ||||||||
Average | 7 | |||||||
Weighted average by Cap. | 13 |
- Stock Market
- Equities
- 688276 Stock
- Sector Changchun BCHT Biotechnology Co.
- Sector revisions

MarketScreener is also available in this country: United States.
Switch edition